These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23600495)

  • 1. Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.
    Esmaeil N; Moayedi B; Gharagozloo M; Maracy MR
    Hemoglobin; 2013; 37(4):404-10. PubMed ID: 23600495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study.
    Adebayo D; Morabito V; Andreola F; Pieri G; Luong TV; Dhillon A; Mookerjee R; Jalan R
    Liver Int; 2015 Dec; 35(12):2564-74. PubMed ID: 25879577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes.
    Chondrogiannis K; Hadziyannis E; Fassoulaki A
    Indian J Med Res; 2014 Nov; 140(5):630-6. PubMed ID: 25579144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.
    Bae CB; Kim SS; Ahn SJ; Cho HJ; Kim SR; Park SY; Song GW; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Shin SJ; Cho SW; Cheong JY
    J Clin Virol; 2013 Dec; 58(4):641-6. PubMed ID: 24210327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
    Joka D; Wahl K; Moeller S; Schlue J; Vaske B; Bahr MJ; Manns MP; Schulze-Osthoff K; Bantel H
    Hepatology; 2012 Feb; 55(2):455-64. PubMed ID: 21993925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
    Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
    World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
    Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
    Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
    Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.
    Ku NO; Strnad P; Bantel H; Omary MB
    Hepatology; 2016 Sep; 64(3):966-76. PubMed ID: 26853542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum M65 as a biomarker for metastatic renal cell carcinoma.
    Yildiz I; Sen F; Kilic L; Keskin S; Duranyildiz D; Bilgin E; Disci R; Ekenel M; Darendeliler E; Bavbek S; Basaran M
    Clin Genitourin Cancer; 2013 Sep; 11(3):290-6. PubMed ID: 23391372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum M30 and M65 levels in melanoma.
    Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
    Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum M30 and M65 levels in patients with breast cancer.
    Tas F; Karabulut S; Yildiz I; Duranyildiz D
    Biomed Pharmacother; 2014 Oct; 68(8):1135-40. PubMed ID: 25465151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.
    Chu T; Jiang L; Ying W; Han B
    Clin Transl Oncol; 2017 Mar; 19(3):326-331. PubMed ID: 27468866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
    de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
    Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Keratin-18 (M65) as a Potential, Early, Non-Invasive Biomarker of Hepatocyte Injury in Alcohol Intoxicated Adolescents-A Preliminary Study.
    Zdanowicz K; Olanski W; Kowalczuk-Kryston M; Bobrus-Chociej A; Werpachowska I; Lebensztejn DM
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.
    Linder S; Olofsson MH; Herrmann R; Ulukaya E
    Expert Rev Mol Diagn; 2010 Apr; 10(3):353-9. PubMed ID: 20370591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.
    Oweira H; Sadeghi M; Volker D; Mieth M; Zidan A; Khajeh E; Ghamarnejad O; Fonouni H; Weiss KH; Schmidt J; Lahdou I; Mehrabi A
    Ann Transplant; 2018 Jun; 23():393-400. PubMed ID: 29880786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.